No abstract available. Aldes JH. Glycocyamine betaine as an adjunct in the treatment of neuromuscular disease patients. J Ark Med Soc. 1957;54(5):186-194.
Read MoreGAA-betaine as therapeutics in neuromuscular disease
- October 15, 1957
- No Comment
Archives
GAA and betaine in motor-neurone disease
- December 1, 1956
- No Comment
No abstract available. Liversedge LA. Glycocyamine and betaine in motor-neurone disease. Lancet. 1956;271(6953):1136-1138. doi: 10.1016/s0140-6736(56)90154-4
Read MoreGAA with betaine in myasthenia gravis
- April 15, 1955
- No Comment
No abstract available. Billig HE Jr, Morehouse LE. Performance and metabolic alterations during betaine glycocyamine feeding in myasthenia gravis. Arch Phys Med Rehabil. 1955;36(4):233-236.
Read MoreGAA-betaine for chronic anterior poliomyelitis
- February 15, 1955
- No Comment
No abstract available. Basom WC, Breck LW, Leonard MH. The effect of betaine and glycocyamine in the management of chronic anterior poliomyelitis. Int Rec Med Gen Pract Clin. 1955;168(2):70-71.
Read MoreBetaine and GAA in the treatment of poliomyelitis
- April 9, 1953
- No Comment
No abstract available. Watkins AL. Betaine and glycocyamine in the treatment of poliomyelitis. N Engl J Med. 1953;248(15):621-623. doi:10.1056/NEJM195304092481501
Read MoreBetaine and GAA for chronic residuals of poliomyelitis
- November 1, 1952
- No Comment
No abstract available. Fallis BD, Lam RL. Betaine and glycocyamine therapy for the chronic residuals of poliomyelitis. J Am Med Assoc. 1952;150(9):851-853. doi: 10.1001/jama.1952.03680090015007
Read MoreBetaine and GAA for acute anterior poliomyelitis
- July 15, 1952
- No Comment
No abstract available. Borsook ME, Billig HK, Golseth JG. Betaine and glycocyamine in the treatment of disability resulting from acute anterior poliomyelitis. Ann West Med Surg. 1952;6(7):423-427.
Read More
Clinical study of GAA and betaine in arthritis
- July 11, 1952
- No Comment
Twenty-two patients with arthritis received 5 gm of glycocyamine and 20.16 gm of betaine by mouth daily, in hospital and after discharge, for periods ranging from 13 to 42 days. A control group of 22 patients, indistinguishable from the treated group, were maintained on the same regimen and given placebos resembling the agents under study. […]
Read MoreGAA-betaine for heart disease
- October 15, 1951
- No Comment
No abstract available. Graybiel A, Patterson CA. Use of betaine and glycocyamine in the treatment of patients with heart disease: preliminary report. Ann West Med Surg. 1951;5(10):863-875.
Read MoreBetaine and GAA for cardiac decompensation
- October 15, 1951
- No Comment
No abstract available. Borsook ME, Borsook H. Treatment of cardiac decompensation with betaine and glycocyamine. Ann West Med Surg. 1951;5(10):830-855.
Read More